
Bone Morphogenetic Protein Market by Type (rhBMP-2, rhBMP-7), Application (Oral Maxillofacial, Reconstruction, Spinal fusion) - Global Forecast 2024-2030
Description
Bone Morphogenetic Protein Market by Type (rhBMP-2, rhBMP-7), Application (Oral Maxillofacial, Reconstruction, Spinal fusion) - Global Forecast 2024-2030
The Bone Morphogenetic Protein Market size was estimated at USD 1.63 billion in 2023 and expected to reach USD 1.88 billion in 2024, at a CAGR 14.81% to reach USD 4.31 billion by 2030.
Global Bone Morphogenetic Protein Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Bone Morphogenetic Protein Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Bone Morphogenetic Protein Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Bone Morphogenetic Protein Market, highlighting leading vendors and their innovative profiles. These include Akron Biotechnology, LLC, AlloSource, Inc., Bioventus LLC, Cellumed Co. Ltd, Ember Therapeutics Inc., Hangzhou Jiuyuan Gene Engineering Co .,Ltd, HiMedia Laboratories, Integra Lifesciences Corporation, Johnson & Johnson Services Inc., Medtronic PLC, Merck KGaA, Olympus Corporation, Orthofix Holdings, Inc., Pfizer, Inc., Prospec-Tany Technogene Ltd., R&D Systems, Inc., ScienCell Research Laboratories, Inc., Sino Biological Inc., Smith & Nephew PLC, Stryker Corporation, Thermo Fisher Scientific, Inc, Xtant Medical Holdings, Inc, and Zimmer Biomet Holdings, Inc..
Market Segmentation & Coverage
This research report categorizes the Bone Morphogenetic Protein Market to forecast the revenues and analyze trends in each of the following sub-markets:
Type
rhBMP-2
rhBMP-7
Application
Oral Maxillofacial
Reconstruction
Spinal fusion
Trauma
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Bone Morphogenetic Protein Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Bone Morphogenetic Protein Market?
3. What are the technology trends and regulatory frameworks in the Bone Morphogenetic Protein Market?
4. What is the market share of the leading vendors in the Bone Morphogenetic Protein Market?
5. Which modes and strategic moves are suitable for entering the Bone Morphogenetic Protein Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
189 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Bone Morphogenetic Protein Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising prevalence rate of sports-related injuries and spinal fusion procedure
- 5.1.1.2. Increasing awareness regarding the bone morphogenetic protein
- 5.1.1.3. Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects
- 5.1.2. Restraints
- 5.1.2.1. High cost of the procedure
- 5.1.3. Opportunities
- 5.1.3.1. Growing demand for minimally invasive medical procedures
- 5.1.3.2. Developing advancements in treatment lines for traumatic injuries
- 5.1.4. Challenges
- 5.1.4.1. Availability of the substitute treatment and products such as bone grafts and scaffolds
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Bone Morphogenetic Protein Market, by Type
- 6.1. Introduction
- 6.2. rhBMP-2
- 6.3. rhBMP-7
- 7. Bone Morphogenetic Protein Market, by Application
- 7.1. Introduction
- 7.2. Oral Maxillofacial
- 7.3. Reconstruction
- 7.4. Spinal fusion
- 7.5. Trauma
- 8. Americas Bone Morphogenetic Protein Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
- 9. Asia-Pacific Bone Morphogenetic Protein Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
- 10. Europe, Middle East & Africa Bone Morphogenetic Protein Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
- 11. Competitive Landscape
- 11.1. FPNV Positioning Matrix
- 11.2. Market Share Analysis, By Key Player
- 11.3. Competitive Scenario Analysis, By Key Player
- 12. Competitive Portfolio
- 12.1. Key Company Profiles
- 12.1.1. Akron Biotechnology, LLC
- 12.1.2. AlloSource, Inc.
- 12.1.3. Bioventus LLC
- 12.1.4. Cellumed Co. Ltd
- 12.1.5. Ember Therapeutics Inc.
- 12.1.6. Hangzhou Jiuyuan Gene Engineering Co .,Ltd
- 12.1.7. HiMedia Laboratories
- 12.1.8. Integra Lifesciences Corporation
- 12.1.9. Johnson & Johnson Services Inc.
- 12.1.10. Medtronic PLC
- 12.1.11. Merck KGaA
- 12.1.12. Olympus Corporation
- 12.1.13. Orthofix Holdings, Inc.
- 12.1.14. Pfizer, Inc.
- 12.1.15. Prospec-Tany Technogene Ltd.
- 12.1.16. R&D Systems, Inc.
- 12.1.17. ScienCell Research Laboratories, Inc.
- 12.1.18. Sino Biological Inc.
- 12.1.19. Smith & Nephew PLC
- 12.1.20. Stryker Corporation
- 12.1.21. Thermo Fisher Scientific, Inc
- 12.1.22. Xtant Medical Holdings, Inc
- 12.1.23. Zimmer Biomet Holdings, Inc.
- 12.2. Key Product Portfolio
- 13. Appendix
- 13.1. Discussion Guide
- 13.2. License & Pricing
- FIGURE 1. BONE MORPHOGENETIC PROTEIN MARKET RESEARCH PROCESS
- FIGURE 2. BONE MORPHOGENETIC PROTEIN MARKET SIZE, 2023 VS 2030
- FIGURE 3. BONE MORPHOGENETIC PROTEIN MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. BONE MORPHOGENETIC PROTEIN MARKET DYNAMICS
- FIGURE 7. BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 8. BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 10. BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 12. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 14. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. BONE MORPHOGENETIC PROTEIN MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 20. BONE MORPHOGENETIC PROTEIN MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.